When a patient is diagnosed with GS and type 2 diabetes, sodium-glucose cotransporter 2 inhibitors (SGLT2i) can be used to control the blood glucose level and assist in raising blood magnesium. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.